Stock Updates

A look at a High Market Cap Stock: Incyte Corporation, INCY

Friday February 24th 2017: Incyte Corporation, INCY is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Incyte Corporation, INCY  has a market cap of 28706.01. Since its IPO date on the 11/04/1993, Incyte Corporation, INCY performance year to date is 40.46%. Today Incyte Corporation, INCY has gained -10.40%, with a current price of 126.19.

Ownership of the company is 0.60% for insider ownership while institutional ownership is 94.60%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 7.30%, with return on investment at 13.20%.

In terms of debt levels and profit levels, Incyte Corporation, INCY is seeing a long-term debt/equity of 1.55. While Total debt/equity is 0. With a profit margin of 9.40%, this is combined with a gross margin of 94.70%, and operating margin of 13.10%. Incyte Corporation ability to meet debt levels, with a current ratio of 3.6, while the quick ratio is 3.6.

For the last year Incyte Corporation, INCY has seen a EPS growth of -63.00%. A performance for the year of 79.32%. The 52-week high is -17.60%, and the 52-week low is 85.50%. The average volume for Incyte Corporation, INCY is 5358166.

With a target price of 157.07, can Incyte Corporation, INCY reach this target? Looking at the value indicators of Incyte Corporation, INCY. Incyte Corporation has a P/E of 261.78 and a forward P/E of 146.1. Perhaps the more useful indicator than P/E, is PEG which has a value of 6.63. Incyte Corporation also has a P/S and a P/B of 25.96 and 63.44 respectively. For P/cash, Incyte Corporation has a value of 35.51, while it is 155.59 for P/free cash flow.

At the current price of 126.19, Incyte Corporation has a dividend yield of *TBA. We see a return on equity of 31.70%.

Looking more long-term Incyte Corporation, is projected to get an EPS growth for the next five years of 39.47%. In the short-term an EPS growth of 447.73% in the next year is forecasted. This is after a EPS growth of -63.00% for this year and for the last five years a 18.70% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment